 |
Celularity
Last updated: October 12, 2024
Founders: Peter Diamandis, Bob Hariri
USA | Funding: $400M (+)
Website: http://www.celularity.com
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
Website: http://www.celularity.com
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
